Skip to content

Clinical trials

Observational Multiple Sclerosis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Sclerosis Phase: Observational Clear all

962 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20023
20036
20048
20059
200614
200719
200822
200915
201026
201127
201238
201329
201435
201534
201630
201744
201850
201966
202061
202197
202259
202365
202468
202553
202670

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed528
Unknown status143
Recruiting119
Not yet recruiting54
Terminated37
Active, not recruiting35
Enrolling by invitation24
Withdrawn18
Suspended4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Biogen46
Novartis Pharmaceuticals30
Bayer28
Merck KGaA, Darmstadt, Germany24
Assiut University22
Fondation Ophtalmologique Adolphe de Rothschild16
Gazi University15
University at Buffalo13
National Institute of Neurological Disorders and Stroke (NINDS)11
University Hospital, Basel, Switzerland11

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Sclerosis962
Multiple Sclerosis, Relapsing-Remitting82
Fatigue50
Parkinson Disease43
Neuromyelitis Optica33
Stroke33
Multiple Sclerosis, Chronic Progressive26
Amyotrophic Lateral Sclerosis19
Recurrence18
Spinal Cord Injuries18

Trials

Showing 76 to 100 of 962. Each trial links to its page on Pharma Observatory.

862 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.